Medical Developments International's quarterly market cap
increased
from Dec. 2024 ($27.94 Mil) to Jun. 2025 ($36.12 Mil) but then
declined
from Jun. 2025 ($36.12 Mil) to Dec. 2025 ($34.23 Mil).
Medical Developments International's annual market cap
declined
from Jun. 2023 ($50.81 Mil) to Jun. 2024 ($25.85 Mil) but then
increased
from Jun. 2024 ($25.85 Mil) to Jun. 2025 ($36.12 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Medical Developments International's Enterprise Value for Today is $20.30 Mil.
Medical Developments International (OTCPK:MDDVF) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Medical Developments International Market Cap Related Terms
Medical Developments International Market Cap Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Medical Developments International Market Cap Chart
For the Drug Manufacturers - Specialty & Generic subindustry, Medical Developments International's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Medical Developments International Market Cap vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Medical Developments International's Market Cap distribution charts can be found below:
* The bar in red indicates where Medical Developments International's Market Cap falls into.
Medical Developments International Market Cap Calculation
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Medical Developments International (MDDVF) has a Market Cap of $30.67 Mil as of Jul. 01, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Medical Developments International and its competitors. According to the industry distribution chart, Medical Developments International ranks #752 out of 1020 companies in the Drug Manufacturers industry, placing it in the top 73.7%.
Is Medical Developments International's Market Cap too high?
Medical Developments International's current Market Cap is $30.67 Mil. The Drug Manufacturers industry median Market Cap is 213.67. Medical Developments International's value of $30.67 Mil is 85.6% below this industry median. Based on the distribution chart, Medical Developments International ranks #752 out of 1020 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Medical Developments International has a GF Score™ of 51/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Medical Developments International's Market Cap compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Medical Developments International ranks #752 out of 1020 companies for Market Cap. This places Medical Developments International in the lower half of its industry. The industry median Market Cap is 213.67. Medical Developments International's value of $30.67 Mil is 85.6% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Drug Manufacturers company?
The median Market Cap among Drug Manufacturers companies is 213.67, based on 1,020 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Medical Developments International's current Market Cap of $30.67 Mil is 85.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Medical Developments International and its competitors. For the Drug Manufacturers industry, the median Market Cap is 213.67 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Medical Developments International's current Market Cap is $30.67 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medical Developments International stock overvalued right now?
Based on GuruFocus' analysis, Medical Developments International (MDDVF) is currently considered Fairly Valued. The stock's GF Value™ is $0.39, compared to a current price of $0.37 — trading 5.1% below its estimated fair value. The current Market Cap is $30.67 Mil and 85.6% below the Drug Manufacturers industry median of 213.67. Medical Developments International's overall GF Score™ is 51/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Medical Developments International (MDDVF), the current Market Cap is $30.67 Mil as of Jul. 01, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Medical Developments International (MDDVF) Overvalued in 2026?
Based on GuruFocus' analysis, Medical Developments International stock appears to be undervalued.
The current stock price of $0.37 is trading 5.1% below its estimated GF Value™ of $0.39.
GuruFocus considers Medical Developments International to be Fairly Valued.
Key valuation signals for MDDVF:
Market Cap: $30.67 Mil
GF Value™: $0.39 vs. price of $0.37 (5.1% below fair value)
Industry Position: 85.6% below the Drug Manufacturers median (#752 of 1020)
No single metric tells the full story. See the MDDVF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Medical Developments International Business Description
Medical Developments International Ltd is a specialized healthcare company. The Company manufactures and distributes Penthrox, a fast-acting trauma and emergency pain relief product, used in hospital emergency departments, ambulance services, sports medicine, and for analgesia during short surgical procedures. The segments of the company are Pain Management and Respiratory. The company derives maximum revenue from the Pain management segment.
51GF Score
Get the complete analysis for MDDVF
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MDDVF has been successfully added to your 
